ANI Pharmaceuticals Inc Cash Flow Quality Index
ANI Pharmaceuticals Inc cash flow quality index. ANI Pharmaceuticals Inc (ANIP) has a Cash Flow Quality Index of 1.10x as of December 2025. Operating cash flow of $30.37 Million exceeds net income of $27.49 Million, indicating high earnings quality where cash backs reported profits. Explore ANIP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ANI Pharmaceuticals Inc (2006–2025)
Cash flow quality index of ANI Pharmaceuticals Inc from 2006 to 2025. Historical Cash Flow Quality Index for ANI Pharmaceuticals Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See ANIP net asset quality score to measure how much of total assets are equity-financed.
ANI Pharmaceuticals Inc Cash Flow Quality Index by Year (2006–2025)
ANI Pharmaceuticals Inc cash flow quality index by year from 2006 to 2025. Year-by-year earnings quality comparison for ANI Pharmaceuticals Inc. For the full cash flow conversion analysis, see ANIP cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.36x | $185.22 Million | $78.34 Million | ▼ -62.7% |
| 2023 | 6.33x | $118.96 Million | $18.78 Million | ▼ -15.4% |
| 2019 | 7.49x | $45.63 Million | $6.09 Million | ▲ +73.0% |
| 2018 | 4.33x | $67.07 Million | $15.49 Million | ▼ -38.0% |
| 2016 | 6.98x | $27.47 Million | $3.93 Million | ▲ +521.9% |
| 2015 | 1.12x | $17.26 Million | $15.38 Million | ▲ +46.5% |
| 2014 | 0.77x | $22.03 Million | $28.75 Million | ▲ +104.2% |
| 2013 | -18.22x | $-5.48 Million | $301.00K | ▼ -917.8% |
| 2006 | -1.79x | $-5.00 Million | $2.79 Million | — |